Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Total Non-Current Liabilities: 2023

Historic Total Non-Current Liabilities for Upstream Bio (UPB) over the last 1 years, with Dec 2023 value amounting to $6.5 million.

  • Upstream Bio's Total Non-Current Liabilities was N/A to $6.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $6.5 million, marking a year-over-year change of. This contributed to the annual value of $6.5 million for FY2023, which is N/A change from last year.
  • Per Upstream Bio's latest filing, its Total Non-Current Liabilities stood at $6.5 million for FY2023.
  • Over the past 5 years, Upstream Bio's Total Non-Current Liabilities peaked at $6.5 million during FY2023, and registered a low of $6.5 million during FY2023.
  • Moreover, its 1-year median value for Total Non-Current Liabilities was $6.5 million (2023), whereas its average is $6.5 million.